CLA (CliftonLarsonAllen) Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,625
Closed -$375K 236
2021
Q3
$375K Sell
1,625
-179
-10% -$44.2K 0.01% 255
2021
Q2
$414K Buy
+1,804
New +$362K 0.02% 245

Other funds holding LLY

CLA (CliftonLarsonAllen) Wealth Advisors's LLY Position: Q4 2021 in Review

CLA (CliftonLarsonAllen) Wealth Advisors sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 1,625 shares — an estimated $375K sold.

CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in LLY in Q2 2021 and held it in 2 quarters. The position peaked at $414K in Q2 2021. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • CLA (CliftonLarsonAllen) Wealth Advisors reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • CLA (CliftonLarsonAllen) Wealth Advisors sold 1,625 Eli Lilly shares in Q4 2021, an estimated $375K.
  • CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in Eli Lilly in Q2 2021 and held it in 2 quarters.
  • CLA (CliftonLarsonAllen) Wealth Advisors's Eli Lilly position peaked at $414K in Q2 2021.
  • 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on CLA (CliftonLarsonAllen) Wealth Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.